Phil’s Journal: Pandemic Disrupts Alzheimer’s Clinical Trials. Including Mine
By Phil Gutis | March 25th, 2020
The response was disappointing but not particularly surprising. Earlier in the day, I had sent a quick email to check in with the staff…
New Alzheimer’s Trial Aims to Defeat Amyloid Before Symptoms Develop
By Lecia Bushak | February 12th, 2020
The world of developing drugs to fight beta-amyloid has been on a rollercoaster ride the last year, but some scientists aren’t giving up. Researchers…
Another Alzheimer’s Trial Cancelled: Lilly, Roche Drugs Fail to Reduce Beta-Amyloid
By Lecia Bushak | February 10th, 2020
Researchers announced today that an Alzheimer’s clinical trial spearheaded by Washington University School of Medicine in St. Louis has been cancelled. Initial data analysis…
China Approves ‘Seaweed Drug’ for Treatment of Alzheimer’s
By Phil Gutis | November 4th, 2019
Building on research into the connection between dementia, inflammation and bacteria in our digestive systems, Chinese officials awarded conditional approval to a seaweed-based drug…
What We Learned From the Latest Alzheimer’s Drug Failure
By Being Patient | January 25th, 2018
Another Alzheimer’s drug has failed in a phase 3 trial, the stage right before drugs go to the Food and Drug Administration for approval….
Follow us